From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Optibiotix: tell us about that £500,000 share trade announced last thing on Friday?

By Tom Winnifrith | Sunday 25 May 2025


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


On Friday morning, Optibiotix (OPTI), whose liar of a CEO had said that it was funded through to profitability later this year, announced a discounted placing at 14p with warrants at 21p. The lying CEO, Steve O’Hara, insisted that £500,000 of that cash came from a specialist “institutional investor with previous experience of investing in companies with weight management products who became aware of OptiBiotix's recent launches of SlimBiome products in the USA.” I bet my entire Cheryl Cole poster collection that this was bollocks.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

CLAI

CelAI madness begets madness

Monday »

ICON

Iconic Labs, the world has gone mad!

Time left: 00:01:14